2022
DOI: 10.3390/polym14061109
|View full text |Cite
|
Sign up to set email alerts
|

Cost Function Analysis Applied to Different Kinetic Release Models of Arrabidaea chica Verlot Extract from Chitosan/Alginate Membranes

Abstract: This work focuses on the mathematical analysis of the controlled release of a standardized extract of A. chica from chitosan/alginate (C/A) membranes, which can be used for the treatment of skin lesions. Four different types of C/A membranes were tested: a dense membrane (CA), a dense and flexible membrane (CAS), a porous membrane (CAP) and a porous and flexible membrane (CAPS). The Arrabidae chica extract release profiles were obtained experimentally in vitro using PBS at 37 °C and pH 7. Experimental data of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(6 citation statements)
references
References 27 publications
0
6
0
Order By: Relevance
“…NYSm concentrations in PBS solutions were determined, and the release efficiency of the drug was assessed as a function of time. The experimental data were further processed by mathematically fitting with the PFO model, which describes a process dependent on concentrations (Equation (7)) [ 52 ] and the Fick’s Law/K–P semi-empirical equation (Equation (8)), in order to establish the type of NYSm release mechanism (Fickian or non-Fickian diffusion) and the stability behavior of the systems [ 53 ]: S r (%) = S 0 (1 − exp (−k r × t), M t /M ∞ = k pr · t n , where S r and S 0 represent the amount of drug released at time t and the initial amount of the drug in solution, k r is the release constant, M t /M ∞ is the fraction of drug release at a specific contact time t, M t and M ∞ refer to the drug released at time t and at infinite time, respectively, k pr and n represent the gel characteristic constant and the diffusion coefficient, respectively. The type of drug release mechanism can be evaluated considering the n parameter value as follows: Fickian diffusion for n values smaller than 0.5, unidirectional or Fickian diffusion if n is equal to 0.5, anomalous or non-Fickian transport for n values higher than 0.5, Case II transport for n = 1 and supercase II transport for n > 1 [ 48 ].…”
Section: Methodsmentioning
confidence: 99%
“…NYSm concentrations in PBS solutions were determined, and the release efficiency of the drug was assessed as a function of time. The experimental data were further processed by mathematically fitting with the PFO model, which describes a process dependent on concentrations (Equation (7)) [ 52 ] and the Fick’s Law/K–P semi-empirical equation (Equation (8)), in order to establish the type of NYSm release mechanism (Fickian or non-Fickian diffusion) and the stability behavior of the systems [ 53 ]: S r (%) = S 0 (1 − exp (−k r × t), M t /M ∞ = k pr · t n , where S r and S 0 represent the amount of drug released at time t and the initial amount of the drug in solution, k r is the release constant, M t /M ∞ is the fraction of drug release at a specific contact time t, M t and M ∞ refer to the drug released at time t and at infinite time, respectively, k pr and n represent the gel characteristic constant and the diffusion coefficient, respectively. The type of drug release mechanism can be evaluated considering the n parameter value as follows: Fickian diffusion for n values smaller than 0.5, unidirectional or Fickian diffusion if n is equal to 0.5, anomalous or non-Fickian transport for n values higher than 0.5, Case II transport for n = 1 and supercase II transport for n > 1 [ 48 ].…”
Section: Methodsmentioning
confidence: 99%
“…Based on the obtained values, lidocaine release capacities over time were calculated, according to the calibration curve previously established ( Figure S2 ). The release data were further processed by applying pseudo-first order (PFO) kinetic model, used to describe the diffusional release mechanisms from porous systems (Equation (7)) [ 41 , 42 ]. Additionally, Korsmeyer–Peppas (K–P) model was used to investigate the lidocaine release mechanism, by processing the first 60% of the experimental data, aiming to describe the lidocaine diffusion mechanisms from the chitosan matrix (Equation (8)) [ 42 ]: where S 0 is the initial amount of the drug and S r represent the cumulative amount of the drug release at time t, k r is the pseudo-first order release constant, M t /M ∞ represents the drug release fraction at time t (M t and M ∞ being the amount of drug released at time t and at infinite time, respectively), k pr is the kinetic K–P constant and n is the characteristic diffusion (release) coefficient, providing information about the type of the release mechanism (n < 0.5—quasi-Fickian diffusion; n = 0.5—unidirectional/Fickian diffusion; 0.5 < n < 1—non-Fickian transport; n = 1—Case II non-Fickian transport; n > 1—non-Fickian supercase II transport [ 43 ].…”
Section: Methodsmentioning
confidence: 99%
“…where M t represents the amount of released drug over time (t), M 0 is the initial drug amount in the system, k is the drug release constant, and n is the release exponent, revealing the drug release mechanism [46].…”
Section: In Vitro Drug Releasementioning
confidence: 99%
“…Based on the results, the Korsmeyer-Peppas kinetic model could best describe the release behavior (R 2 > 0.95). In this model, n was less than 0.5 for the coated samples, meaning that the drug diffuses through the partially swollen matrix and solutionfilled networks [46,76,77].…”
Section: In Vitro Drug Releasementioning
confidence: 99%